Vascular Ehlers-Danlos Syndrome (VEDS) is caused by pathogenic variants of the COL3A1 gene, resulting abnormal Type III collagen protein. This impacts the body…

Vascular Ehlers-Danlos Syndrome

~Estimated

~$10 – $6,250

Baylor College of MedicineNCT05994664

Phase 3Remote eligible

A Phase 3 Randomized, Double-Blind, Decentralized Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in the Treatment of Patients With COL3A1-Positive Vascular Ehlers-Danlos Syndrome

This is a prospective, Phase 3, randomized, double-blind, placebo-controlled efficacy study to evaluate celiprolol in patients genetically confirmed as COL3A1-…

Vascular Ehlers-Danlos Syndrome

~Estimated

~$10 – $8,750

Acer Therapeutics Inc.NCT05432466